Zhou X - Search Results

1

Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: Development and validation of the systemic inflammation response index-covered score.

Chu Y, Liu Y, Jiang Y, Ge X, Yuan D, Ding M, Qu H, Liu F, Zhou X, Wang X. Chu Y, et al. Among authors: zhou x. Cancer Med. 2023 Apr;12(8):9570-9582. doi: 10.1002/cam4.5733. Epub 2023 Mar 3. Cancer Med. 2023. PMID: 36866830 Free PMC article.

2

Role of microRNAs in chronic lymphocytic leukemia (Review).

Zhou XX, Wang X. Zhou XX, et al. Mol Med Rep. 2013 Sep;8(3):719-25. doi: 10.3892/mmr.2013.1599. Epub 2013 Jul 23. Mol Med Rep. 2013. PMID: 23900739 Review.

3

Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma.

Fang X, Zhou X, Wang X. Fang X, et al. Among authors: zhou x. Biomark Res. 2013 Nov 15;1(1):30. doi: 10.1186/2050-7771-1-30. Biomark Res. 2013. PMID: 24252186 Free PMC article.

4

Klotho: a novel biomarker for cancer.

Zhou X, Wang X. Zhou X, et al. J Cancer Res Clin Oncol. 2015 Jun;141(6):961-9. doi: 10.1007/s00432-014-1788-y. Epub 2014 Aug 3. J Cancer Res Clin Oncol. 2015. PMID: 25086986 Review.

5

Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.

Zhou X, Lu K, Geng L, Li X, Jiang Y, Wang X. Zhou X, et al. Medicine (Baltimore). 2014 Dec;93(28):e258. doi: 10.1097/MD.0000000000000258. Medicine (Baltimore). 2014. PMID: 25526450 Free PMC article. Review.

6

The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.

Lu K, Fang XS, Feng LL, Jiang YJ, Zhou XX, Liu X, Li PP, Chen N, Ding M, Wang N, Zhang J, Wang X. Lu K, et al. Among authors: zhou xx. Cancer Lett. 2015 Apr 10;359(2):250-8. doi: 10.1016/j.canlet.2015.01.021. Epub 2015 Jan 27. Cancer Lett. 2015. PMID: 25636517

7

The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.

Lu K, Chen N, Zhou XX, Ge XL, Feng LL, Li PP, Li XY, Geng LY, Wang X. Lu K, et al. Among authors: zhou xx. Biochem Biophys Res Commun. 2015 Aug 14;464(1):292-8. doi: 10.1016/j.bbrc.2015.06.145. Epub 2015 Jun 24. Biochem Biophys Res Commun. 2015. PMID: 26116769

8

Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia.

Li PP, Lu K, Geng LY, Zhou XX, Li XY, Wang X. Li PP, et al. Among authors: zhou xx. Mol Med Rep. 2016 Jun;13(6):4934-8. doi: 10.3892/mmr.2016.5111. Epub 2016 Apr 12. Mol Med Rep. 2016. PMID: 27082823

9

GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.

Geng L, Lu K, Li P, Li X, Zhou X, Li Y, Wang X. Geng L, et al. Among authors: zhou x. Oncotarget. 2017 Jul 25;8(30):48701-48710. doi: 10.18632/oncotarget.9792. Oncotarget. 2017. PMID: 27275540 Free PMC article.

10

WP1066 exhibits antitumor efficacy in nasal‑type natural killer/T-cell lymphoma cells through downregulation of the STAT3 signaling pathway.

Geng L, Li X, Zhou X, Fang X, Yuan D, Wang X. Geng L, et al. Among authors: zhou x. Oncol Rep. 2016 Nov;36(5):2868-2874. doi: 10.3892/or.2016.5091. Epub 2016 Sep 15. Oncol Rep. 2016. PMID: 27633398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,323 results

Search Page

Filters